Literature DB >> 4406925

Inhibition of gluconeogenesis at the phosphoenolpyruvate carboxykinase and pyruvate carboxylase reactions, as a means of cancer chemotherapy.

J Gold.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1974        PMID: 4406925     DOI: 10.1159/000224889

Source DB:  PubMed          Journal:  Oncology        ISSN: 0030-2414            Impact factor:   2.935


× No keyword cloud information.
  4 in total

Review 1.  Unconventional therapies for cancer: 4. Hydrazine sulfate. Task Force on Alternative Therapies of the Canadian Breast Cancer Research Initiative.

Authors:  E Kaegi
Journal:  CMAJ       Date:  1998-05-19       Impact factor: 8.262

2.  Key role of hydrazine to the interaction between oxaloacetic against phosphoenolpyruvic carboxykinase (PEPCK): ONIOM calculations.

Authors:  Pongthep Prajongtat; Darinee Sae-Tang Phromyothin; Supa Hannongbua
Journal:  J Mol Model       Date:  2013-04-27       Impact factor: 1.810

3.  Clinical study of hydrazine sulfate in advanced cancer patients.

Authors:  E Spremulli; G L Wampler; W Regelson
Journal:  Cancer Chemother Pharmacol       Date:  1979       Impact factor: 3.333

4.  Betulin-3,28-diphosphate as a Component of Combination Cytostatic Drugs for the Treatment of Ehrlich Ascites Carcinoma In Vitro and In Vivo Experiments.

Authors:  Olga Vorobyova; Olga Deryabina; Darina Malygina; Nadezhda Plotnikova; Anna Solovyeva; Kseniya Belyaeva; Nina Melnikova
Journal:  Sci Pharm       Date:  2018-04-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.